ADIL stock

Adial Pharmaceuticals Inc (ADIL) financials · $6.0M cap

Adial Pharmaceuticals Inc (ADIL) $6.0M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$7.8M-$8.3M
Net Income-$8.0M-$13.2M
EPS (Diluted)$-11.93$-2.72
Cached annual balance sheet
LineFY2025FY2024
Total Assets$6.7M$5.0M
Current Assets$6.2M$4.1M
Cash & Equivalents$5.9M$3.8M
Inventory$0$0
PP&E$0$0
Total Liabilities$1.4M$975.9K
Current Liabilities$1.4M$975.9K
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity$5.3M$4.1M
Retained Earnings-$90.0M-$82.0M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$6.5M-$6.9M
CapEx$0$0
Investing Cash Flow$150.0K$0
Financing Cash Flow$8.5M$7.8M
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow$0$0

FAQ

What is ADIL P/E and revenue?

Adial Pharmaceuticals Inc (ADIL) $6.0M cap.

What is ADIL revenue?

Adial Pharmaceuticals Inc last cached revenue is $0 (FY2025).

Is ADIL profitable?

Adial Pharmaceuticals Inc last cached net income is -$8.0M.

What are ADIL total assets?

Adial Pharmaceuticals Inc last cached total assets are $6.7M.

What is ADIL free cash flow?

Adial Pharmaceuticals Inc last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.